What is the Current Clinical Impact of the CYP2CTG Haplotype?

Clin Pharmacol Ther. 2024 Feb;115(2):183. doi: 10.1002/cpt.3094. Epub 2023 Nov 20.

Magnus Ingelman-Sundberg¹, Marin Jukic^{1

2}, Line Skute Bråten^{3

4}, Marianne Kristiansen Kringen^{3

4}, Espen Molden^{3

5}

¹ Section of Pharmacogenetics, Department of Physiology and Pharmacology, Biomedicum 5B, Karolinska Institutet, Stockholm, Sweden.
² Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
³ Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
⁴ Department of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
⁵ Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.

No abstract available

Publication types